Genetic variations in CHRNA7 or CHRFAM7 and susceptibility to dementia

Current Drug Targets

Volumn 13, Issue 5, 2012, Pages 637-643

  Neri, Monica ^a   Bonassi, Stefano ^a   Russo, Patrizia ^a  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Alzheimer disease; CHRFAM7A; CHRNA7; Dementia; Genetic association studies; Genetic polymorphism; Genetic predisposition to disease

Indexed keywords

AMYLOID BETA PROTEIN; BUNGAROTOXIN RECEPTOR; NICOTINIC RECEPTOR; PROTEIN CHRFAM7; UNCLASSIFIED DRUG;

ARTICLE; COPY NUMBER VARIATION; DEMENTIA; DIFFUSE LEWY BODY DISEASE; FUSION GENE; GENE DUPLICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENETIC VARIABILITY; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; MILD COGNITIVE IMPAIRMENT; MOLECULAR INTERACTION; PICK PRESENILE DEMENTIA; SINGLE NUCLEOTIDE POLYMORPHISM; ALZHEIMER DISEASE; ANIMAL; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; REVIEW;

ALZHEIMER DISEASE; ANIMALS; DEMENTIA; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, NICOTINIC;

EID: 84860452492     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Jürgensen S, Ferreira ST. Nicotinic receptors, amyloid-beta, and synaptic failure in Alzheimer's disease. J Mol Neurosci 2010; 40: 221-9.
2. Schliebs R, Arendt T. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm 2006; 113: 1625-44.
3. Parri RH, Dineley TK. Nicotinic acetylcholine receptor interaction with beta-amyloid: molecular, cellular, and physiological consequences. Curr Alzheimer Res 2010; 7: 27-39.
4. Hernandez C, Dineley KT. α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both? Curr Drug Targets 2012; 13: 613-22.
5. Freedman R, Coon H, Myles-Worsley M, et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 1997; 94: 587-92.
6. Flomen RH, Collier DA, Osborne S, et al. Association study of CHRFAM7A copy number and 2 bp deletion polymorphisms with schizophrenia and bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 571-5.
7. Taske NL, Williamson MP, Makoff A, et al. Evaluation of the positional candidate gene CHRNA7 at the juvenile myoclonic epilepsy locus (EJM2) on chromosome 15q13-14. Epilepsy Res 2002; 49: 157-72.
8. Neubauer BA, Fiedler B, Himmelein B, et al. Centrotemporal spikes in families with rolandic epilepsy: linkage to chromosome 15q14. Neurology 1998; 51: 1608-12.
9. Casaubon LK, Melanson M, Lopes-Cendes I, et al. The gene responsible for a severe form of peripheral neuropathy and agenesis of the corpus callosum maps to chromosome 15q. Am J Hum Genet 1996; 58: 28-34.
10. Grewal HK, Almullahassani A, Grewal J, Slater JD. Partial agenesis of the corpus callosum in a patient with juvenile myoclonic epilepsy. Epileptic Disord 2007; 9: 461-4.
11. Ueda M, Katayama Y, Kamiya T, et al. Hereditary spastic paraplegia with a thin corpus callosum and thalamic involvement in Japan. Neurology 1998; 51: 1751-4.
12. Wassink TH, and Collaborative Linkage Study of Autism. Chromosome 15 microdeletions and duplications in autism. Mol Psychiatry 1999; 4: S15.
13. Robinson L, Morris D, Turic D, et al. Linkage disequilibrium mapping in reading disability. Mol Psychiatry 1999; 4: S8-S9.
14. Stitzel JA. Naturally occurring genetic variability in the nicotinic acetylcholine receptor alpha4 and alpha7 subunit genes and phenotypic diversity in humans and mice. Front Biosci 2008; 13: 477-91.
15. Gault J, Robinson M, Berger R, et al. Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics 1998; 52: 173-85.
16. Riley B, Williamson M, Collier D, Wilkie H, Makoff A. A 3-Mb map of a large Segmental duplication overlapping the alpha7- nicotinic acetylcholine receptor gene (CHRNA7) at human 15q13- q14. Genomics 2002; 79: 197-209.
17. Sinkus ML, Lee MJ, Gault J, et al. A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia. Brain Res 2009; 1291: 1-11.
18. Araud T, Graw S, Berger R, Lee M, Neveu E, Bertrand D, Leonard S. The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function. Biochem Pharmacol 2011; 82: 904-14.
19. de Lucas-Cerrillo AM, Maldifassi MC, Arnalich F, et al. Function of partially duplicated human alpha 7 nicotinic receptor subunit CHRFAM7A Gene. J Biol Chem 2011; 286: 594-606.
20. Levin ED. α7 Nicotinic Receptors and Cognition. Curr Drug Targets 2012; 13(5): 602-6.
21. Hunter RG. Stress and the α7 Nicotinic Acetylcholine Receptor. Curr Drug Targets 2012; 13(5): 607-12.
22. Kawamata J, Suzuki S, Shimohama S. α7 nicotinic acetylcholine receptor mediated neuroprotection in Parkinson's Disease. Curr Drug Targets 2012; 13(5): 623-30.
23. Kelso ML, Oestreich JH. Traumatic brain injury: central and peripheral role of alpha7 nAChR. Curr Drug Targets 2012; 13(5): 631-6.
24. Vasto S, Candore G, Duro G, Lio D, Grimaldi MP, Caruso C. Alzheimer's disease and genetics of inflammation: a pharmacogenomic vision. Pharmacogenomics 2007; 8: 1735-45.
25. Serretti A, Olgiati P, De Ronchi D. Genetics of Alzheimer's disease. A rapidly evolving field. J Alzheimer's Dis 2007; 12: 73-92.
26. Piccardi M, Congiu D, Squassina A, et al. Alzheimer's disease: case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample. Am J Med Genet B: Neuropsychiatr Genet 2007; 144B: 895-9.
27. Ugolini D, Neri M, Casilli C, Bonassi S. Development of search filters for retrieval of literature on the molecular epidemiology of cancer. Mutat Res 2010; 701: 107-10.
28. Swaminathan S, Kim S, Shen L, et al. The alzheimer's disease neuroimaging initiative adni. genomic copy number analysis in alzheimer's disease and mild cognitive impairment: an ADNI study. Int J Alzheimers Dis 2011; 2011: 729478.
29. Heinzen EL, Need AC, Hayden KM, et al. Genome-wide scan of copy number variation in late-onset Alzheimer's disease. J Alzheimers Dis 2010; 19: 69-77.
30. Barabash A, Marcos A, Ancín I, et al. APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease. Neurobiol Aging 2009; 30: 1254-64.
31. Fehér A, Juhász A, Rimanóczy A, Csibri E, Kálmán J, Janka Z. Association between a genetic variant of the alpha-7 nicotinic acetylcholine receptor subunit and four types of dementia. Dement Geriatr Cogn Disord 2009; 28: 56-62.
32. Carson R, Craig D, Hart D, et al. Genetic variation in the alpha 7 nicotinic acetylcholine receptor is associated with delusional symptoms in Alzheimer's disease. Neuromolecular Med 2008; 10: 377-84.
33. Carson R, Craig D, McGuinness B, et al. Alpha7 nicotinic acetylcholine receptor gene and reduced risk of Alzheimer's disease. J Med Genet 2008; 45: 244-8.
34. Li H, Wetten S, Li L, et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 2008; 65: 45-53.
35. Reiman EM, Webster JA, Myers AJ, et al. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 2007; 54: 713-20.
36. Cook LJ, Ho LW, Wang L, et al. Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study. Am J Med Genet B Neuropsychiatr Genet 2005; 132B: 5-8.
37. Kawamata J, Shimohama S. Association of novel and established polymorphisms in neuronal nicotinic acetylcholine receptors with sporadic Alzheimer's disease. J Alzheimers Dis 2002; 4: 71-6.
38. Liou YJ, Lai IC, Hong CJ, Liu HC, Liu TY, Tsai SJ. Association analysis of the partially duplicated alpha7 nicotinic acetylcholine receptor genetic variant and Alzheimer's disease. Dement Geriatr Cogn Disord 2001; 12: 301-4.
39. Gault J, Hopkins J, Berger R, et al. Comparison of polymorphisms in the alpha7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects. Am J Med Genet B Neuropsychiatr Genet 2003; 123B: 39-49.
40. Leonard S, Gault J, Hopkins J, et al. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry 2002; 59: 1085-96.
41. Naj AC, Jun G, Beecham GW, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 2011; 43: 436-41.
42. Hollingworth P, Harold D, Sims R, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. 2. Nat Genet 2011; 43: 429-35.
43. Shaw CA, Li Y, Wiszniewska J, Chasse S, et al. Olfactory copy number association with age at onset of Alzheimer disease. Neurology 2011; 76: 1302-9.
44. Lee JH, Cheng R, Barral S, et al. Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch Neurol 2011; 68: 320-8.
45. Belbin O, Carrasquillo MM, Crump M, et al. Investigation of 15 of the top candidate genes for late-onset Alzheimer's disease. Hum Genet 2011; 129: 273-82.
46. Kim S, Swaminathan S, Shen L, et al. Alzheimer's Disease Neuroimaging Initiative. Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. 6. Neurology 2011; 76: 69-79.
47. Sherva R, Baldwin CT, Inzelberg R, et al. Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP data. J Alzheimers Dis 2011; 23: 349-59.